Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002713:Chlorine / Q000008:administration & dosage; D005153:Facial Neoplasms / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D006968:Hypersensitivity, Delayed; D007642:Keratosis / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009578:Nitrobenzenes / Q000008:administration & dosage*; D009824:Ointments; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology; D014228:Triaziquone / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D009578:Nitrobenzenes; D009824:Ointments; D002713:Chlorine; D014228:Triaziquone; D005472:Fluorouracil